Cleared Traditional

CARDNAV (K120282) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2012
Decision
314d
Days
Class 2
Risk

K120282 is an FDA 510(k) clearance for the CARDNAV. Classified as Interventional Fluoroscopic X-ray System (product code OWB), Class II - Special Controls.

Submitted by Paieon, Inc. (Rosh Haayin, IL). The FDA issued a Cleared decision on December 10, 2012 after a review of 314 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1650 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Paieon, Inc. devices

Submission Details

510(k) Number K120282 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 31, 2012
Decision Date December 10, 2012
Days to Decision 314 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
207d slower than avg
Panel avg: 107d · This submission: 314d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OWB Interventional Fluoroscopic X-ray System
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1650
Definition Interventional Fluoroscopy
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - OWB Interventional Fluoroscopic X-ray System

All 177
Devices cleared under the same product code (OWB) and FDA review panel - the closest regulatory comparables to K120282.
ARTIS ONE
K133580 · Siemens Medical Solutions USA, Inc. · Apr 2014
ARTIS ZEE/ZEEGO WITH CSX-10 DETECTOR SW VC21
K122644 · Siemens Medical Solutions USA, Inc. · May 2013
ARTIS Q AND Q.ZEN- MODULAR ANGIOGRAPHIC SYSTEM
K123529 · Siemens Medical Solutions USA, Inc. · Feb 2013
SYNGO AORTIC VALVEGUIDE SOFTWARE
K113027 · Siemens Medical Solutions USA, Inc. · Nov 2011
AXIOM LUMINOS DRF
K062623 · Siemens Medical Solutions USA, Inc. · Aug 2007
AXIOM ARTIS - MODULAR ANGIOGRAPHIC SYSTEM
K052202 · Siemens Medical Solutions USA, Inc. · Mar 2006